Tannic acid attenuates hepatic oxidative stress, apoptosis and inflammation by activating the Keap1‑Nrf2/ARE

Mengying Li1, Panpan Liu1, Yucong Xue1

  • 1School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China.

Oncology Reports
|October 1, 2020
PubMed

Insights

Tannic acid (TA) protects against arsenic trioxide (ATO)-induced liver injury by activating the Keap1-Nrf2/ARE pathway. This reduces oxidative stress, apoptosis, and inflammation, offering a potential therapeutic strategy for arsenic poisoning.

Area of Science:

  • Toxicology
  • Hepatology
  • Molecular Biology

Background:

  • Arsenic trioxide (ATO) is a toxic metalloid that can cause significant liver damage.
  • Oxidative stress, apoptosis, and inflammation are key mechanisms underlying ATO-induced hepatotoxicity.
  • The Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway plays a crucial role in cellular defense against oxidative stress.

Purpose of the Study:

  • To investigate the protective effects of tannic acid (TA) against arsenic trioxide (ATO)-induced liver injury in rats.
  • To elucidate the underlying molecular mechanisms, particularly focusing on the Keap1-Nrf2/ARE signaling pathway.

Main Methods:

  • Rats were treated with TA followed by ATO administration.
  • Liver function (ALT, AST), histological changes, oxidative stress markers (ROS, MDA), apoptosis markers (Bcl-2, Bax, caspase-3), and inflammatory cytokines (IL-1β, IL-6, TNF-α) were assessed.
  • Western blot analysis was used to determine the protein expression levels of Keap1, Nrf2, HO-1, NQO1, and γ-GCS.

Main Results:

  • TA treatment ameliorated ATO-induced liver damage, normalizing ALT and AST levels.
  • TA significantly increased antioxidant enzyme activities while reducing oxidative stress markers (ROS, MDA).
  • TA inhibited ATO-induced apoptosis and inflammation, evidenced by altered expression of apoptosis-related proteins and cytokines.
  • TA treatment upregulated the protein expression of Nrf2, Keap1, HO-1, NQO1, and γ-GCS.

Conclusions:

  • Tannic acid exhibits significant hepatoprotective effects against arsenic trioxide toxicity.
  • The protective mechanism involves the activation of the Keap1-Nrf2/ARE signaling pathway.
  • TA's ability to mitigate oxidative stress, apoptosis, and inflammation makes it a promising agent for treating arsenic-induced liver injury.